Trial Profile
A Multicenter, Randomized, Double-blind, Clinical Study to Investigate the Efficacy and Safety of Treatment With Tamsulosin 0.2mg Mono and Tamsulosin 0.2mg, Finasteride 5mg Combination Therapy in Patients With LUTS/BPH
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Tamsulosin (Primary) ; Finasteride
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Acronyms ABSOLUTE
- 13 May 2014 Planned End Date changed from 1 Jun 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov.
- 13 May 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 07 Jan 2013 New trial record